Entyvio 108 MG/0.68 ML pen 0.68ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AK8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,547
Award facts
- Contract value 100% obligated
- $15,547.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,547.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Entyvio 108 mg/0.68 mL pens (0.68 mL). The contract, with an ultimate completion date of February 12, 2026, is a non-set-aside award issued under the company's parent organization Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00 and extending through December 2031, serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. Performance of this delivery order will be executed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate operations.
AmerisourceBergen Drug Corp, as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to compete on a full and open basis for pharmaceutical supply requirements. This delivery order reflects the ongoing demand for specialty pharmaceutical products within the military medical supply chain and AmerisourceBergen's established role as a primary supplier to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1AK8?
SPE2DR26F1AK8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F1AK8 worth?
The government has obligated $15,547 on SPE2DR26F1AK8.
Is contract SPE2DR26F1AK8 an order under another contract?
Yes. SPE2DR26F1AK8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AK8 competed?
The extent of competition for SPE2DR26F1AK8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award